Who
Joseph R. Young
SVP, Finance, Chief Acct Offcr
Company insider
Files Form 4 as: SVP, Finance, Chief Acct Offcr, Vera Therapeutics.
In numbers
- Trades disclosed
- 39
- Buys
- 2
- Sells
- 5
- Bought
- $80K
- Sold
- $2.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 May 2021
- Last trade
- 11 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 14 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $20K5,000 at $3.94 | filing |
| 11 Sep 2026filed 14 Sep 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 11 Sep 2026filed 14 Sep 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 11 Sep 2026filed 14 Sep 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $20K5,000 at $3.94 | filing |
| 13 Mar 2026filed 16 Mar 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $39K10,000 at $3.94 | filing |
| 13 Mar 2026filed 16 Mar 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 13 Mar 2026filed 16 Mar 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 13 Mar 2026filed 16 Mar 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $39K10,000 at $3.94 | filing |
| 23 Feb 2026filed 25 Feb 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $131K3,117 at $41.98 | filing |
| 23 Feb 2026filed 25 Feb 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $131K3,117 at $41.98 | filing |
| 4 Feb 2026filed 6 Feb 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 13 Nov 2025filed 13 Nov 2025 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 13 Nov 2025filed 13 Nov 2025 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code M | $39K10,000 at $3.94 | filing |
| 11 Nov 2025filed 13 Nov 2025 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Sold | $436K15,000 at $29.06 | filing |
| 18 Feb 2025filed 20 Feb 2025 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,500 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | VERA Vera TherapeuticsBiotechnology | SEC FORM 4 Code A | —10,740 at $0.00 | filing |
| 16 May 2024filed 17 May 2024 | VERA Vera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,651 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.